Literature DB >> 12686529

Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.

Carlos Fernández-del Castillo1, Javier Targarona, Sarah P Thayer, David W Rattner, William R Brugge, Andrew L Warshaw.   

Abstract

HYPOTHESIS: Widespread use of computed tomography and ultrasound has led to the identification of increasing numbers of patients with asymptomatic cystic lesions of the pancreas.
DESIGN: Retrospective case series of patients with pancreatic cystic lesions.
SETTING: University-affiliated tertiary care referral center. PATIENTS: Two hundred twelve patients with pancreatic cystic lesions seen in our surgical practice during 5 years (April 1997-March 2002). MAIN OUTCOME MEASURES: Presence or absence of symptoms, cyst size and location, cytologic or pathologic diagnosis, surgical treatment, and outcome.
RESULTS: Seventy-eight (36.7%) of 212 patients were asymptomatic. Incidental cysts were smaller (3.3 +/- 1.9 vs 4.6 +/- 2.7 cm; P<.001) and were found in older patients (65 +/- 13 vs 56 +/- 15 years; P<.001). Seventy-eight percent of the asymptomatic patients and 87% of those with symptoms underwent surgery, with a single operative death in the entire group (0.5%). Seventeen percent of asymptomatic cysts were serous cystadenomas; 28%, mucinous cystic neoplasms; 27%, intraductal papillary mucinous neoplasms; and 2.5%, ductal adenocarcinomas. The respective numbers for symptomatic cysts were 7%, 16%, 40%, and 9%. Ten percent of asymptomatic patients had a variety of other cystic lesions, and in 12%, no definitive cytologic or pathologic diagnosis was obtained. Overall, 17% of asymptomatic patients had in situ or invasive cancer, and 42% had a premalignant lesion. When evaluated as a function of size, only 1 (3.5%) of 28 asymptomatic cysts smaller than 2 cm had cancer compared with 13 (26%) of 50 cysts larger than 2 cm (P =.04). The proportion of premalignant lesions, however, remained high in both groups (46% and 38%, respectively). Pseudocysts comprised only 3.8% of asymptomatic cysts compared with 19.4% of symptomatic cysts (P =.003).
CONCLUSIONS: Incidental pancreatic cysts are common, occur in older patients, are smaller than symptomatic cysts, and are unlikely to be pseudocysts. More than half of them are either malignant or premalignant lesions and therefore cannot be dismissed.

Entities:  

Mesh:

Year:  2003        PMID: 12686529      PMCID: PMC4403874          DOI: 10.1001/archsurg.138.4.427

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  22 in total

1.  The prevalence and characterization of simple hepatic cysts by ultrasound examination.

Authors:  P A Gaines; M A Sampson
Journal:  Br J Radiol       Date:  1989-04       Impact factor: 3.039

2.  Endoscopic ultrasonography diagnosis of pancreatic cystic disease.

Authors:  H Maguchi; M Osanai; N Yanagawa; K Takahashi; H Itoh; A Katanuma; T Obara; Y Kohgo
Journal:  Endoscopy       Date:  1998-08       Impact factor: 10.093

Review 3.  The role of endoscopic ultrasound in pancreatic disorders.

Authors:  W R Brugge
Journal:  Int J Pancreatol       Date:  1996-08

4.  Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic.

Authors:  E V Loftus; B A Olivares-Pakzad; K P Batts; M C Adkins; D H Stephens; M G Sarr; E P DiMagno
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

6.  Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients.

Authors:  A L Warshaw; C C Compton; K Lewandrowski; G Cardenosa; P R Mueller
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

7.  The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects.

Authors:  C M Pyke; J A van Heerden; T V Colby; M G Sarr; A L Weaver
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

8.  Cystic neoplasms of the pancreas.

Authors:  S G ReMine; D Frey; R L Rossi; J L Munson; J W Braasch
Journal:  Arch Surg       Date:  1987-04

9.  Cystic tumors mistaken for pancreatic pseudocysts.

Authors:  A L Warshaw; P L Rutledge
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

Review 10.  Serous cystadenoma of the pancreas with invasive growth: benign or malignant?

Authors:  H Abe; K Kubota; M Mori; K Miki; M Minagawa; T Noie; W Kimura; M Makuuchi
Journal:  Am J Gastroenterol       Date:  1998-10       Impact factor: 10.864

View more
  170 in total

1.  Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

Authors:  Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur
Journal:  Radiology       Date:  2014-11-12       Impact factor: 11.105

Review 2.  Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis.

Authors:  Robert Grützmann; Stefan Post; Hans Detlev Saeger; Marco Niedergethmann
Journal:  Dtsch Arztebl Int       Date:  2011-11-18       Impact factor: 5.594

3.  Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Hanno Matthaei; Alexis L Norris; Athanasios C Tsiatis; Kelly Olino; Seung-Mo Hong; Marco dal Molin; Michael G Goggins; Marcia Canto; Karen M Horton; Keith D Jackson; Paola Capelli; Giuseppe Zamboni; Laura Bortesi; Toru Furukawa; Shinichi Egawa; Masaharu Ishida; Shigeru Ottomo; Michiaki Unno; Fuyuhiko Motoi; Christopher L Wolfgang; Barish H Edil; John L Cameron; James R Eshleman; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

4.  Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy.

Authors:  Roberto Valente; Gabriele Capurso; Paola Pierantognetti; Elsa Iannicelli; Matteo Piciucchi; Adriana Romiti; Paolo Mercantini; Alberto Larghi; Giulia Francesca Federici; Viola Barucca; Maria Falchetto Osti; Emilio Di Giulio; Vincenzo Ziparo; Gianfranco Delle Fave
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

5.  Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis.

Authors:  Jordan M Winter; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; David Chang; Taylor S Riall; Joann Coleman; Patricia K Sauter; Marcia Canto; Ralph H Hruban; Richard D Schulick; Michael A Choti; Charles J Yeo
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

6.  Pancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle.

Authors:  Luca Barresi; Ilaria Tarantino; Antonino Granata; Gabriele Curcio; Mario Traina
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

7.  Incidentally discovered benign pancreatic cystic neoplasms not communicating with the ductal system: MR/MRCP imaging appearance and evolution.

Authors:  R Manfredi; M Bonatti; M D'Onofrio; S Mehrabi; R Salvia; W Mantovani; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

8.  Incidental pancreatic cysts: do we really know what we are watching?

Authors:  Camilo Correa-Gallego; Cristina R Ferrone; Sarah P Thayer; Jennifer A Wargo; Andrew L Warshaw; Carlos Fernández-Del Castillo
Journal:  Pancreatology       Date:  2010-05-17       Impact factor: 3.996

Review 9.  Solitary true cyst of pancreas: report of a case and review of literature.

Authors:  Mohammad Atif Khan; G R Verma
Journal:  J Gastrointest Cancer       Date:  2010-06

Review 10.  Precursors to pancreatic cancer.

Authors:  Ralph H Hruban; Anirban Maitra; Scott E Kern; Michael Goggins
Journal:  Gastroenterol Clin North Am       Date:  2007-12       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.